- antihistamine (trade name Phenergan) used to treat allergies; also an antiemetic used to treat motion sickness (同)Phenergan
1:1 mixture (racemate)
|Systematic (IUPAC) name|
|Oral, rectal, IV, IM, topical|
|Bioavailability||88% absorbed but after first-pass metabolism reduced to 25% absolute bioavailability|
|Metabolism||Hepatic glucuronidation and sulfoxidation|
|Excretion||Renal and biliary|
CAS Registry Number
|Y (what is this?)|
Promethazine is a neuroleptic medication and first-generation antihistamine of the phenothiazine family. The drug has strong sedative and weak antipsychotic effects. It also reduces motion sickness and has antiemetic and anticholinergic properties. In some countries it is prescribed for insomnia when benzodiazepines are contraindicated. It is available in many countries under the brand names Phenergan, Promethegan, Romergan, Fargan, Farganesse, Fenazin, Prothiazine, Avomine, Atosil, Receptozine, Lergigan, Pipolphen, and (in the UK) Sominex.
- 1 Indications
- 2 Chemistry
- 3 Pharmacology
- 4 Side effects
- 5 Product liability lawsuit
- 6 See also
- 7 References
- 8 External links
- As a sedative
- For preoperative sedation and to counteract postnarcotic nausea
- To reduce nervousness, restlessness and agitation caused by psychiatric conditions (used for this purpose mainly in Europe)
- As antiallergic medication to combat hay fever (allergic rhinitis), etc., or to treat allergic reactions, alone or in combination with oral decongestants such as pseudoephedrine
- As an adjunct treatment for anaphylactoid conditions (IM/IV route preferred)
- Together with codeine or dextromethorphan against cough
- As a motion sickness or seasickness remedy when used with ephedrine or pseudoephedrine
- To combat moderate to severe morning sickness and hyperemesis gravidarum: In the UK, promethazine is drug of first choice, being preferred as an older drug with which there is a greater experience of use in pregnancy (second in line being metoclopramide or prochlorperazine).
- Previously, it was used as an antipsychotic, although it is generally not administered for this purpose now; promethazine has only approximately 1/10 of the antipsychotic strength of chlorpromazine.
- Treatment for migraines; however, other similar medications, like Compazine, have been shown to have a more favorable treatment profile, and are used almost exclusively over promethazine.
Solid promethazine hydrochloride is a white to faint-yellow, practically odorless, crystalline powder. Slow oxidation may occur upon prolonged exposure to air, usually causing blue discoloration. Its hydrochloride salt is freely soluble in water and somewhat soluble in alcohol. Promethazine is a chiral compound, occurring as a mixture of enantiomers (pictured).
Promethazine, 10-(2-dimethylaminopropyl)phenothiazine, is synthesized by alkylating phenothiazine with 1-chloro-2-(dimethylamino)propane in the presence of sodium amide:
Promethazine, a phenothiazine derivative, is structurally different from the neuroleptic phenothiazines, with similar but different effects. It acts primarily as a strong antagonist of the H1 receptor (antihistamine) and a moderate mACh receptor antagonist (anticholinergic), and also has weak to moderate affinity for the 5-HT2A, 5-HT2C, D2, and α1-adrenergic receptors, where it acts as an antagonist at all sites, as well.
Another notable use of promethazine is as a local anesthetic, by blockade of sodium channels.
Some common side effects include:
- Tardive dyskinesia
- Confusion in the elderly
- Drowsiness, dizziness, fatigue, more rarely vertigo
- Dry mouth
- Respiratory depression in patients under age of two and in those with severely compromised pulmonary function
- Chest discomfort/pressure (typically in cases when patient is already taking medication for high blood pressure)
- Euphoria (very rare, except with high IV doses and/or coadministration with opioids/CNS depressants)
- Akathisia 
- Short temper/irritability
Extremely rare side effects include:
- Neuroleptic malignant syndrome
Because of potential for more severe side effects, this drug is on the list to avoid in the elderly. (See NCQA’s HEDIS Measure: Use of High Risk Medications in the Elderly). In many countries (including the US and UK), promethazine is contraindicated in children less than two years of age, and strongly cautioned against in children between two and six, due to problems with respiratory depression and sleep apnoea.
Product liability lawsuit
In 2009, the US Supreme Court ruled on a product liability case involving promethazine. Diana Levine, a woman suffering from a migraine, was administered Wyeth's Phenergan via IV push. The drug was injected improperly, resulting in gangrene and subsequent amputation of her right forearm below the elbow. A state jury awarded her $6 million in punitive damages.
The case was appealed to the Supreme Court on grounds of federal preemption and substantive due process. The Supreme Court upheld the lower courts' rulings, stating that "Wyeth could have unilaterally added a stronger warning about IV-push administration" without acting in opposition to federal law. In effect, this means drug manufacturers can be held liable for injuries if warnings of potential adverse effects, approved by the US Food and Drug Administration (FDA), are deemed insufficient by state courts.
On September 9, 2009, the FDA required a black box warning for injection be put on promethazine, stating the contraindication for subcutaneous administration. The preferred administrative route is intramuscular, which reduces risk of surrounding muscle and tissue damage.
- Purple drank (a recreational drug concoction containing promethazine)
- Strenkoski-Nix LC, Ermer J, DeCleene S, Cevallos W, Mayer PR (August 2000). "Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects". American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists 57 (16): 1499–505. PMID 10965395.
- Paton DM, Webster DR (1985). "Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines)". Clinical Pharmacokinetics 10 (6): 477–97. doi:10.2165/00003088-198510060-00002. PMID 2866055.
- RxList: Promethazine
- RxList Indications for Promethazine
- British National Formulary (March 2001). "4.6 Drugs used in nausea and Vertigo - Vomiting of pregnancy". BNF (45 ed.). .
- http://www.cja-jca.org/cgi/reprint/6/4/375.pdf[dead link]
- "Prochlorperazine vs. promethazine for headache treatment in the emergency department: a randomized controlled trial.". pubmed.gov. Oct 2008. Retrieved Jan 30, 2015.
- "RxList: Promethazine Description". 2007-06-21.
- Beringer, Paul; Troy, David A.; Remington, Joseph P. (2006). Remington: The Science and Practice of Pharmacy. Hagerstown, MD: Lippincott Williams & Wilkins. p. 1545. ISBN 0-7817-4673-6.
- P. Charpentier, U.S. Patent 2,530,451 (1950)
- S.B. Sidney, J.A. Nicholson, U.S. Patent 2,607,773 (1952)
- Fiorella D, Rabin RA, Winter JC (October 1995). "The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis". Psychopharmacology 121 (3): 347–56. doi:10.1007/bf02246074. PMID 8584617.
- Seeman P, Watanabe M, Grigoriadis D et al. (November 1985). "Dopamine D2 receptor binding sites for agonists. A tetrahedral model". Molecular Pharmacology 28 (5): 391–9. PMID 2932631. CS1 maint: Explicit use of et al. (link)
- Burt DR, Creese I, Snyder SH (April 1977). "Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain". Science 196 (4287): 326–8. doi:10.1126/science.847477. PMID 847477.
- Jagadish Prasad, P. (2010). Conceptual Pharmacology. Universities Press. pp. 295, 303, 598. ISBN 978-81-7371-679-9. Retrieved 27 November 2011.
- Cordingley Neurology
- Starke P, Weaver J, Chowdhury B (2005). "Boxed warning added to promethazine labeling for pediatric use". N Eng J Med. 352 (5): 2653. doi:10.1056/nejm200506233522522.
- Liptak, Adam (2001-09-18). "Drug Label, Maimed Patient and Crucial Test for Justices". The New York Times. Retrieved 2008-10-31.
- Stout, David (2009-03-04). "Drug Approval Is Not a Shield From Lawsuits, Justices Rule". The New York Times. Retrieved 2009-03-04.
- "Information for Healthcare Professionals: Intravenous Promethazine and Severe Tissue Injury, Including Gangrene". 2013-08-15.
- "Promethazine". U.S. National Library of Medicine and National Institutes of Health.
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 妊娠の悪心および嘔吐の治療および転帰 treatment and outcome of nausea and vomiting of pregnancy
- 2. 妊娠時のブプレノルフィン補充療法 buprenorphine substitution therapy in pregnancy
- 3. 妊産婦の施設間搬送 inter facility maternal transport
- 4. 緩和ケアにおける呼吸困難の評価とマネージメント assessment and management of dyspnea in palliative care
- 5. 制吐剤の特性 characteristics of antiemetic drugs
- Spectroscopic approach of the interaction study of amphiphilic drugs with the serum albumins.
- Khan AB, Khan JM, Ali MS, Khan RH, Din KU.SourceDepartment of Chemistry, Aligarh Muslim University, Aligarh 202002, India.
- Colloids and surfaces. B, Biointerfaces.Colloids Surf B Biointerfaces.2011 Oct 15;87(2):447-53. Epub 2011 Jun 13.
- The interaction of the amphiphilic drugs, i.e., amitriptyline hydrochloride (AMT) and promethazine hydrochloride (PMT), with serum albumins (i.e., human serum albumin (HSA) and bovine serum albumin (BSA)), has been examined by the various spectroscopic techniques, like fluorescence, UV-vis, and circ
- PMID 21726987
- A fast ultra high pressure liquid chromatographic method for qualification and quantification of pharmaceutical combination preparations containing paracetamol, acetyl salicylic acid and/or antihistaminics.
- Deconinck E, Sacre PY, Baudewyns S, Courselle P, De Beer J.SourceDepartment of Pharmaco-Bromatology, Section Medicinal Products, Scientific Institute of Public Health (IPH), J. Wytmansstraat 14, 1050 Brussels, Belgium.
- Journal of pharmaceutical and biomedical analysis.J Pharm Biomed Anal.2011 Sep 10;56(2):200-9. Epub 2011 May 19.
- A fully validated UHPLC method for the identification and quantification of pharmaceutical preparations, containing paracetamol and/or acetyl salicylic acid, combined with anti-histaminics (phenylephrine, pheniramine maleate, diphenhydramine, promethazine) and/or other additives as quinine sulphate,
- PMID 21665401
- 小檜山 文子,佐藤 雅子,金子 毅
- 分析化学 = Japan analyst 58(8), 661-665, 2009-08-05
- マイクロ抽出法の一つである分散液液マイクロ抽出（dispersive liquid liquid microextraction，DLLME）法により，ベンゾジアゼピン系薬剤であるフルニトラゼパム及びニメタゼパムの低濃度水溶液試料から抽出を行い，ガスクロマトグラフィー質量分析による測定を行った．ベンゾジアゼピン系薬剤に対する抽出溶媒，分散溶媒の種類等の最適条件を検討し，同条件で三環系抗うつ薬剤であ …
- NAID 10025979820
- Effects of Histamine H_1-Antagonists on Sleep-Awake State in Rats Placed on a Grid Suspended over Water or on Sawdust(Pharmacology)
- TOKUNAGA Shin,TSUTSUI Ryuki,OBARA Yoshihito,ISHIDA Takayuki,KAMEI Chiaki
- Biological & Pharmaceutical Bulletin 32(1), 51-54, 2009-01-01
- … Diphenhydramine, chlorpheniramine and promethazine caused a significant decrease in the awake time and increase in non-REM sleep time in rats placed on the grid suspended over water for 1-2h and/or 2-3h after administration. … Different from these two drugs, promethazine caused a significant decrease in the awake time and increase in non-REM sleep time 1-2h and 2-3h after administration even when rats were placed on sawdust at a relatively high dose. …
- NAID 110007021741
- Promethazine is a first-generation antihistamine of the phenothiazine family. The drug has anti-motion sickness, antiemetic, and anticholinergic effects, as well as a strong sedative effect and in some countries is prescribed for insomnia when ...
|拡張検索||「promethazine methylenedisalicylate」「promethazine teoclate」「promethazine hydrochloride」「hydroxyethylpromethazine」|
- 塩酸プロメタジン promethazine hydrochloride